Examining the Efficacy of Fecal Microbiota Transplantation (FMT) and Dietary Fiber in Patients With Ulcerative Colitis
Status:
Recruiting
Trial end date:
2025-01-01
Target enrollment:
Participant gender:
Summary
A double-blind, randomized, placebo-controlled clinical trial examining the efficacy and
safety of Fecal Microbiota Transplantation (FMT) and high fiber supplementation in patients
with active mild to moderate Ulcerative Colitis (UC). All enrolled subjects will provide
serological, stool and mucosal specimen at each clinic visit to help further define the
alterations in microbial profiles and immune cell function in response to psyllium fiber
after FMT treatment.